Bill Text: FL S1268 | 2011 | Regular Session | Introduced


Bill Title: Pharmacy

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2011-05-07 - Indefinitely postponed and withdrawn from consideration [S1268 Detail]

Download: Florida-2011-S1268-Introduced.html
       Florida Senate - 2011                                    SB 1268
       
       
       
       By Senator Oelrich
       
       
       
       
       14-00665-11                                           20111268__
    1                        A bill to be entitled                      
    2         An act relating to pharmacy; amending s. 465.189,
    3         F.S.; revising the types of vaccines that pharmacists
    4         are authorized to administer; authorizing pharmacy
    5         interns to administer the vaccines under certain
    6         circumstances; authorizing pharmacists and pharmacy
    7         interns to administer an epinephrine autoinjection
    8         under certain circumstances; revising protocol
    9         requirements for vaccine administration and the duties
   10         of supervising physicians under such protocols;
   11         revising requirements for training programs,
   12         certifications, and patient records related to vaccine
   13         administration; amending s. 465.003, F.S.; revising
   14         terminology to conform to changes made by the act;
   15         providing an effective date.
   16  
   17  Be It Enacted by the Legislature of the State of Florida:
   18  
   19         Section 1. Section 465.189, Florida Statutes, is amended to
   20  read:
   21         465.189 Administration of vaccines and epinephrine
   22  autoinjection influenza virus immunizations.—
   23         (1) A pharmacist, and a pharmacy intern having proper
   24  certification and working under the pharmacist’s supervision,
   25  Pharmacists may administer, influenza virus immunizations to
   26  adults within the framework of an established protocol under a
   27  supervising supervisory practitioner who is a physician licensed
   28  under chapter 458 or chapter 459, the following:
   29         (a) Influenza vaccine to an adult 18 years of age or older.
   30         (b) Varicella zoster vaccine to an adult 60 years of age or
   31  older.
   32         (c) Pneumococcal vaccine to an adult 65 years of age or
   33  older.
   34         (d) Epinephrine using an autoinjector delivery system to an
   35  adult 18 years of age or older who is suffering an anaphylactic
   36  reaction.
   37  
   38  The Each protocol must shall contain specific procedures for
   39  addressing any unforeseen adverse allergic reaction to the
   40  vaccine or epinephrine autoinjection influenza virus
   41  immunizations.
   42         (2) A pharmacist may not enter into a protocol unless he or
   43  she maintains at least $200,000 of professional liability
   44  insurance and has completed training on the vaccines and
   45  epinephrine autoinjection in influenza virus immunizations as
   46  provided in this section.
   47         (3) A pharmacist who administers, or whose pharmacy intern
   48  administers, a vaccine or epinephrine autoinjection must
   49  administering influenza virus immunizations shall maintain and
   50  make available patient records using the same standards for
   51  confidentiality and maintenance of such records as those that
   52  are imposed on health care practitioners under s. 456.057. These
   53  records must shall be maintained for a minimum of 5 years.
   54         (4) The decision by a supervising physician supervisory
   55  practitioner to enter into a protocol under this section is a
   56  professional decision on the part of the physician practitioner,
   57  and a person may not interfere with a supervising physician’s
   58  supervisory practitioner’s decision to enter as to entering into
   59  such a protocol. A pharmacist may not enter into a protocol that
   60  is to be performed while acting as an employee without the
   61  written approval of the owner of the pharmacy. Pharmacists shall
   62  forward immunization records to the department for inclusion in
   63  the state registry of immunization information.
   64         (5) Any pharmacist or pharmacy intern seeking to administer
   65  a vaccine or epinephrine autoinjection influenza virus
   66  immunizations to adults under this section must be certified to
   67  administer the vaccine or epinephrine autoinjection influenza
   68  virus immunizations pursuant to a certification program approved
   69  by the Board of Pharmacy in consultation with the Board of
   70  Medicine and the Board of Osteopathic Medicine. The
   71  certification program shall, at a minimum, require that the
   72  pharmacist or pharmacy intern attend at least 20 hours of
   73  continuing education classes approved by the board. The program
   74  shall have a curriculum of instruction concerning the safe and
   75  effective administration of the vaccines listed in subsection
   76  (1) and epinephrine autoinjection influenza virus immunizations,
   77  including, but not limited to, potential adverse allergic
   78  reactions to the vaccines or epinephrine autoinjection influenza
   79  virus immunizations.
   80         (6) The written protocol between the pharmacist and
   81  supervising physician must include particular terms and
   82  conditions imposed by the supervising physician upon the
   83  pharmacist relating to the administration of a vaccine or
   84  epinephrine autoinjection influenza virus immunizations by the
   85  pharmacist or pharmacy intern working under the pharmacist’s
   86  supervision. The written protocol must shall include, at a
   87  minimum, specific categories and conditions among patients for
   88  whom the supervising physician authorizes the pharmacist or
   89  pharmacy intern to administer a vaccine or epinephrine
   90  autoinjection influenza virus immunizations. The terms, scope,
   91  and conditions set forth in the written protocol between the
   92  pharmacist and the supervising physician must be appropriate to
   93  the pharmacist’s or pharmacy intern’s training and certification
   94  for the vaccine or epinephrine autoinjection immunization. A
   95  pharmacist, or pharmacy intern working under the pharmacist’s
   96  supervision, Pharmacists who is have been delegated the
   97  authority to administer a vaccine or epinephrine autoinjection
   98  influenza virus immunizations by the supervising physician must
   99  shall provide evidence of current certification by the Board of
  100  Pharmacy to the supervising physician. A supervising physician
  101  must physicians shall review the administration of the vaccine
  102  or epinephrine autoinjection influenza virus immunizations by
  103  the pharmacist, or a pharmacy intern working under the
  104  pharmacist’s supervision, pharmacists under such physician’s
  105  supervision pursuant to the written protocol, and this review
  106  shall take place as outlined in the written protocol. The
  107  process and schedule for the review shall be outlined in the
  108  written protocol between the pharmacist and the supervising
  109  physician.
  110         (7) The pharmacist shall submit to the Board of Pharmacy a
  111  copy of his or her protocol or written agreement to administer
  112  the vaccine or epinephrine autoinjection influenza virus
  113  immunizations.
  114         Section 2. Subsection (13) of section 465.003, Florida
  115  Statutes, is amended to read:
  116         465.003 Definitions.—As used in this chapter, the term:
  117         (13) “Practice of the profession of pharmacy” includes
  118  compounding, dispensing, and consulting concerning contents,
  119  therapeutic values, and uses of any medicinal drug; consulting
  120  concerning therapeutic values and interactions of patent or
  121  proprietary preparations, whether pursuant to prescriptions or
  122  in the absence and entirely independent of such prescriptions or
  123  orders; and other pharmaceutical services. For purposes of this
  124  subsection, “other pharmaceutical services” means the monitoring
  125  of the patient’s drug therapy and assisting the patient in the
  126  management of his or her drug therapy, and includes review of
  127  the patient’s drug therapy and communication with the patient’s
  128  prescribing health care provider as licensed under chapter 458,
  129  chapter 459, chapter 461, or chapter 466, or similar statutory
  130  provision in another jurisdiction, or such provider’s agent or
  131  such other persons as specifically authorized by the patient,
  132  regarding the drug therapy. However, nothing in this subsection
  133  does not may be interpreted to permit an alteration of a
  134  prescriber’s directions, the diagnosis or treatment of any
  135  disease, the initiation of any drug therapy, the practice of
  136  medicine, or the practice of osteopathic medicine, unless
  137  otherwise permitted by law. The term “practice of the profession
  138  of pharmacy” also includes any other act, service, operation,
  139  research, or transaction incidental to, or forming a part of,
  140  any of the foregoing acts, requiring, involving, or employing
  141  the science or art of any branch of the pharmaceutical
  142  profession, study, or training, and shall expressly permit a
  143  pharmacist to transmit information from persons authorized to
  144  prescribe medicinal drugs to their patients. The term practice
  145  of the profession of pharmacy also includes the administration
  146  of certain vaccines and epinephrine autoinjection influenza
  147  virus immunizations to adults pursuant to s. 465.189.
  148         Section 3. This act shall take effect July 1, 2011.

feedback